Block Listing Return

Oxford Biomedica PLC
02 January 2025
 

For Immediate Release

2 January 2025



 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING RETURN


Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 July 2024

To:

31 December 2024

Balance of unallotted securities under scheme(s) from previous return:

294,719

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

11,197

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

283,522






 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 and 2024 Long Term Incentive Plan

Period of return:

From:

1 July 2024

To:

31 December 2024

Balance of unallotted securities under scheme(s) from previous return:

393,299

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

600,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

433,280

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

560,019







 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 and 2024 Deferred Bonus Plan

Period of return:

From:

1 July 2024

To:

31 December 2024

Balance of unallotted securities under scheme(s) from previous return:

286,791

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

300,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

211,730

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

375,061






 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 July 2024

To:

31 December 2024

Balance of unallotted securities under scheme(s) from previous return:

339,753

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

713

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

339,040

 

Name of contact:

Natalie Walter, Company Secretary

Telephone number of contact:

01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Oxford Biomedica (OXB)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today